Advancing Access to Diagnostic Innovation Essential for UHC and AMR Prevention

NCT04081051 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
17294
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Foundation for Innovative New Diagnostics, Switzerland

Collaborators